{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T05:36:37Z","timestamp":1791351397137,"version":"4.3.1"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,12,30]],"date-time":"2015-12-30T00:00:00Z","timestamp":1451433600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1038\/nrneph.2015.208","type":"journal-article","created":{"date-parts":[[2015,12,30]],"date-time":"2015-12-30T05:00:57Z","timestamp":1451451657000},"page":"147-156","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":137,"title":["The mucosa\u2013kidney axis in IgA nephropathy"],"prefix":"10.1038","volume":"12","author":[{"given":"J\u00fcrgen","family":"Floege","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Feehally","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,12,30]]},"reference":[{"key":"BFnrneph2015208_CR1","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1681\/ASN.V11122395","volume":"11","author":"J Floege","year":"2000","unstructured":"Floege, J. & Feehally, J. IgA nephropathy: recent developments. J. Am. Soc. Nephrol. 11, 2395\u20132403 (2000).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2015208_CR2","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1056\/NEJMra1206793","volume":"368","author":"RJ Wyatt","year":"2013","unstructured":"Wyatt, R. J. & Julian, B. A. IgA nephropathy. N. Engl. J. Med. 368, 2402\u20132414 (2013).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph2015208_CR3","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.it.2015.06.006","volume":"36","author":"AJ Macpherson","year":"2015","unstructured":"Macpherson, A. J., K\u00f6ller, Y. & McCoy, K. D. The bilateral responsiveness between intestinal microbes and IgA. Trends Immunol. 36, 460\u2013470 (2015).","journal-title":"Trends Immunol."},{"key":"BFnrneph2015208_CR4","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1089\/dna.2014.2639","volume":"33","author":"KW Leong","year":"2014","unstructured":"Leong, K. W. & Ding, J. L. The unexplored roles of human serum IgA. DNA Cell Biol. 33, 823\u2013829 (2014).","journal-title":"DNA Cell Biol."},{"key":"BFnrneph2015208_CR5","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/mi.2011.36","volume":"4","author":"JE Bakema","year":"2011","unstructured":"Bakema, J. E. & van Egmond, M. The human immunoglobulin A Fc receptor Fc\u03b1RI: a multifaceted regulator of mucosal immunity. Mucosal Immunol. 4, 612\u2013624 (2011).","journal-title":"Mucosal Immunol."},{"key":"BFnrneph2015208_CR6","doi-asserted-by":"crossref","first-page":"717","DOI":"10.4049\/jimmunol.151.2.717","volume":"151","author":"T Schweighoffer","year":"1993","unstructured":"Schweighoffer, T. et al. Selective expression of integrin alpha 4 beta 7 on a subset of human CD4+ memory T cells with hallmarks of gut-trophism. J. Immunol. 151, 717\u2013729 (1993).","journal-title":"J. Immunol."},{"key":"BFnrneph2015208_CR7","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1159\/000024294","volume":"121","author":"M Tarkowski","year":"2000","unstructured":"Tarkowski, M., Pacheco, K. A. & Rosenwasser, L. J. The effect of antigen stimulation on \u03b14, \u03b21 and \u03b27 chain integrin expression and function in CD4+ cells Int. Arch. Allergy Immunol. 121, 25\u201333 (2000).","journal-title":"Int. Arch. Allergy Immunol."},{"key":"BFnrneph2015208_CR8","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/mi.2015.2","volume":"8","author":"J Travers","year":"2015","unstructured":"Travers, J. & Rothenberg, M. E. Eosinophils in mucosal immune responses. Mucosal Immunol. 8, 464\u2013475 (2015).","journal-title":"Mucosal Immunol."},{"key":"BFnrneph2015208_CR9","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1038\/ki.1994.110","volume":"45","author":"SJ Harper","year":"1994","unstructured":"Harper, S. J. et al. Expression of J chain mRNA in duodenal IgA plasma cells in IgA nephropathy. Kidney Int. 45, 836\u2013844 (1994).","journal-title":"Kidney Int."},{"key":"BFnrneph2015208_CR10","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/S0272-6386(12)81056-0","volume":"24","author":"SJ Harper","year":"1994","unstructured":"Harper, S. J. et al. Increased immunoglobulin A and immunoglobulin A1 cells in bone marrow trephine biopsy specimens in immunoglobulin A nephropathy. Am. J. Kidney Dis. 24, 888\u2013892 (1994).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph2015208_CR11","doi-asserted-by":"publisher","first-page":"3620","DOI":"10.1093\/ndt\/gfp441","volume":"24","author":"J Barratt","year":"2009","unstructured":"Barratt, J., Eitner, F., Feehally, J. & Floege, J. Immune complex formation in IgA nephropathy: a case of the 'right' antibodies in the 'wrong' place at the 'wrong' time? Nephrol. Dial. Transplant. 24, 3620\u20133623 (2009).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph2015208_CR12","doi-asserted-by":"publisher","first-page":"3520","DOI":"10.1681\/ASN.2006060658","volume":"17","author":"AC Smith","year":"2006","unstructured":"Smith, A. C., Molyneux, K., Feehally, J. & Barratt, J. O-glycosylation of serum IgA1 antibodies against mucosal and systemic antigens in IgA nephropathy. J. Am. Soc. Nephrol. 17, 3520\u20133528 (2006).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2015208_CR13","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1093\/ndt\/gfm228","volume":"22","author":"A Batra","year":"2007","unstructured":"Batra, A., Smith, A. C., Feehally, J. & Barratt, J. T-cell homing receptor expression in IgA nephropathy. Nephrol. Dial. Transplant. 22, 2540\u20132548 (2007).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph2015208_CR14","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1053\/j.ajkd.2014.06.036","volume":"65","author":"LL Liu","year":"2015","unstructured":"Liu, L. L. et al. Tonsillectomy for IgA nephropathy: a meta-analysis. Am. J. Kidney Dis. 65, 80\u201387 (2015).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph2015208_CR15","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1038\/ng.3118","volume":"46","author":"K Kiryluk","year":"2014","unstructured":"Kiryluk, K. et al. Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens. Nat. Genet. 46, 1187\u20131196 (2014).","journal-title":"Nat. Genet."},{"key":"BFnrneph2015208_CR16","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1681\/ASN.2014010096","volume":"26","author":"L Zhu","year":"2015","unstructured":"Zhu, L. et al. Variants in complement factor H and complement factor H-related protein genes, CFHR3 and CFHR1, affect complement activation in IgA nephropathy. J. Am. Soc. Nephrol. 26, 1195\u20131204 (2015).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2015208_CR17","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1046\/j.1523-1755.63.s83.17.x","volume":"63","author":"K Suzuki","year":"2003","unstructured":"Suzuki, K. et al. Incidence of latent mesangial IgA deposition in renal allograft donors in Japan. Kidney Int. 63, 86\u201394 (2003).","journal-title":"Kidney Int."},{"key":"BFnrneph2015208_CR18","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1681\/ASN.2012010063","volume":"23","author":"E Gutierrez","year":"2012","unstructured":"Gutierrez, E. et al. Long-term outcomes of IgA nephropathy presenting with minimal or no proteinuria. J. Am. Soc. Nephrol. 23, 1753\u20131760 (2012).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2015208_CR19","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/ki.2010.335","volume":"79","author":"RS Dwivedi","year":"2011","unstructured":"Dwivedi, R. S., Herman, J. G., McCaffrey, T. A. & Raj, D. S. Beyond genetics: epigenetic code in chronic kidney disease. Kidney Int. 79, 23\u201332 (2011).","journal-title":"Kidney Int."},{"key":"BFnrneph2015208_CR20","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/j.1365-2249.1992.tb03040.x","volume":"88","author":"F Fortune","year":"1992","unstructured":"Fortune, F., Courteau, M., Williams, D. G. & Lehner, T. T and B cell responses following immunization with tetanus toxoid in IgA nephropathy. Clin. Exp. Immunol. 88, 62\u201367 (1992).","journal-title":"Clin. Exp. Immunol."},{"key":"BFnrneph2015208_CR21","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/BF00918269","volume":"12","author":"FB Waldo","year":"1992","unstructured":"Waldo, F. B. Systemic immune response after mucosal immunization in patients with IgA nephropathy. J. Clin. Immunol. 12, 21\u201326 (1992).","journal-title":"J. Clin. Immunol."},{"key":"BFnrneph2015208_CR22","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1038\/ki.1996.396","volume":"50","author":"JW de Fijter","year":"1996","unstructured":"de Fijter, J. W. et al. Deficient IgA1 immune response to nasal cholera toxin subunit B in primary IgA nephropathy. Kidney Int. 50, 952\u2013961 (1996).","journal-title":"Kidney Int."},{"key":"BFnrneph2015208_CR23","first-page":"300","volume":"3","author":"L Layward","year":"1995","unstructured":"Layward, L., Allen, A. C., Hattersley, J. M., Harper, S. J. & Feehally, J. Response to mucosal antigen challenge in IgA nephropathy. Exp. Nephrol. 3, 300\u2013307 (1995).","journal-title":"Exp. Nephrol."},{"key":"BFnrneph2015208_CR24","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/S0272-6386(99)70141-1","volume":"33","author":"J Barratt","year":"1999","unstructured":"Barratt, J. et al. Exaggerated systemic antibody response to mucosal Helicobacter pylori infection in IgA nephropathy. Am. J. Kidney Dis. 33, 1049\u20131057 (1999).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph2015208_CR25","doi-asserted-by":"publisher","first-page":"608","DOI":"10.2353\/ajpath.2010.090428","volume":"176","author":"R Schmitt","year":"2010","unstructured":"Schmitt, R. et al. Tissue deposits of IgA-binding streptococcal M proteins in IgA nephropathy and Henoch\u2013Sch\u00f6nlein purpura. Am. J. Pathol. 176, 608\u2013618 (2010).","journal-title":"Am. J. Pathol."},{"key":"BFnrneph2015208_CR26","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/j.1523-1755.2004.00714.x","volume":"66","author":"A Koyama","year":"2004","unstructured":"Koyama, A. et al. Staphylococcus aureus cell envelope antigen is a new candidate for the induction of IgA nephropathy. Kidney Int. 66, 121\u2013132 (2004).","journal-title":"Kidney Int."},{"key":"BFnrneph2015208_CR27","doi-asserted-by":"publisher","first-page":"e99006","DOI":"10.1371\/journal.pone.0099006","volume":"9","author":"M De Angelis","year":"2014","unstructured":"De Angelis, M. et al. Microbiota and metabolome associated with immunoglobulin A nephropathy (IgAN). PLoS ONE 9, e99006 (2014).","journal-title":"PLoS ONE"},{"key":"BFnrneph2015208_CR28","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s00248-015-0592-9","volume":"70","author":"M Piccolo","year":"2015","unstructured":"Piccolo, M. et al. Salivary microbiota associated with immunoglobulin A nephropathy. Microb. Ecol. 70, 557\u2013565 (2015).","journal-title":"Microb. Ecol."},{"key":"BFnrneph2015208_CR29","first-page":"275","volume":"29","author":"J Nagy","year":"1988","unstructured":"Nagy, J., Scott, H. & Brandtzaeg, P. Antibodies to dietary antigens in IgA nephropathy. Clin. Nephrol. 29, 275\u2013279 (1988).","journal-title":"Clin. Nephrol."},{"key":"BFnrneph2015208_CR30","doi-asserted-by":"publisher","first-page":"e94677","DOI":"10.1371\/journal.pone.0094677","volume":"9","author":"S Moeller","year":"2014","unstructured":"Moeller, S. et al. Lack of serologic evidence to link IgA nephropathy with celiac disease or immune reactivity to gluten. PLoS ONE 9, e94677 (2014).","journal-title":"PLoS ONE"},{"key":"BFnrneph2015208_CR31","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/BF00853592","volume":"1","author":"J Feehally","year":"1987","unstructured":"Feehally, J. et al. Response of circulating immune complexes to food challenge in relapsing IgA nephropathy. Pediatr. Nephrol. 1, 581\u2013586 (1987).","journal-title":"Pediatr. Nephrol."},{"key":"BFnrneph2015208_CR32","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/j.1365-2249.1992.tb06952.x","volume":"89","author":"S Jackson","year":"1992","unstructured":"Jackson, S. et al. IgA-containing immune complexes after challenge with food antigens in patients with IgA nephropathy. Clin. Exp. Immunol. 89, 315\u2013320 (1992).","journal-title":"Clin. Exp. Immunol."},{"key":"BFnrneph2015208_CR33","doi-asserted-by":"publisher","first-page":"364","DOI":"10.5414\/CNP74364","volume":"74","author":"H Kloster Smerud","year":"2010","unstructured":"Kloster Smerud, H. et al. Gastrointestinal sensitivity to soy and milk proteins in patients with IgA nephropathy. Clin. Nephrol. 74, 364\u2013371 (2010).","journal-title":"Clin. Nephrol."},{"key":"BFnrneph2015208_CR34","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.1093\/ndt\/gfp133","volume":"24","author":"HK Smerud","year":"2009","unstructured":"Smerud, H. K. et al. Gluten sensitivity in patients with IgA nephropathy. Nephrol. Dial. Transplant. 24, 2476\u20132481 (2009).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph2015208_CR35","first-page":"72","volume":"33","author":"R Coppo","year":"1990","unstructured":"Coppo, R. et al. Effects of a gluten-free diet in primary IgA nephropathy. Clin. Nephrol. 33, 72\u201386 (1990).","journal-title":"Clin. Nephrol."},{"key":"BFnrneph2015208_CR36","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1111\/j.1523-1755.2005.00324.x","volume":"67","author":"T Honkanen","year":"2005","unstructured":"Honkanen, T. et al. Small bowel cyclooxygenase 2 (COX-2) expression in patients with IgA nephropathy. Kidney Int. 67, 2187\u20132195 (2005).","journal-title":"Kidney Int."},{"key":"BFnrneph2015208_CR37","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.1046\/j.1523-1755.1999.00471.x","volume":"55","author":"I Rantala","year":"1999","unstructured":"Rantala, I. et al. Small bowel T cells, HLA class II antigen DR, and GroEL stress protein in IgA nephropathy. Kidney Int. 55, 2274\u20132280 (1999).","journal-title":"Kidney Int."},{"key":"BFnrneph2015208_CR38","first-page":"72","volume":"26","author":"R Coppo","year":"1986","unstructured":"Coppo, R. et al. Mediterranean diet and primary IgA nephropathy. Clin. Nephrol. 26, 72\u201382 (1986).","journal-title":"Clin. Nephrol."},{"key":"BFnrneph2015208_CR39","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1159\/000184859","volume":"48","author":"RJ Hene","year":"1988","unstructured":"Hene, R. J., Schuurman, H. J. & Kater, L. Immunoglobulin A subclass-containing plasma cells in the jejunum in primary IgA nephropathy and in Henoch\u2013Sch\u00f6nlein purpura. Nephron 48, 4\u20137 (1988).","journal-title":"Nephron"},{"key":"BFnrneph2015208_CR40","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1093\/ndt\/16.3.513","volume":"16","author":"G Rostoker","year":"2001","unstructured":"Rostoker, G., Delchier, J. C. & Chaumette, M. T. Increased intestinal intra-epithelial T lymphocytes in primary glomerulonephritis: a role of oral tolerance breakdown in the pathophysiology of human primary glomerulonephritides? Nephrol. Dial. Transplant. 16, 513\u2013517 (2001).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph2015208_CR41","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1136\/gut.33.2.206","volume":"33","author":"E Savilahti","year":"1992","unstructured":"Savilahti, E., Reunala, T. & Maki, M. Increase of lymphocytes bearing the \u03b3\/\u03b4 T cell receptor in the jejunum of patients with dermatitis herpetiformis. Gut 33, 206\u2013211 (1992).","journal-title":"Gut"},{"key":"BFnrneph2015208_CR42","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1203\/00006450-199012000-00005","volume":"28","author":"E Savilahti","year":"1990","unstructured":"Savilahti, E., Arato, A. & Verkasalo, M. Intestinal \u03b3\/\u03b4 receptor-bearing T lymphocytes in celiac disease and inflammatory bowel diseases in children. Constant increase in celiac disease. Pediatr. Res. 28, 579\u2013581 (1990).","journal-title":"Pediatr. Res."},{"key":"BFnrneph2015208_CR43","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1038\/ki.1997.427","volume":"52","author":"C Olive","year":"1997","unstructured":"Olive, C. et al. Expression of the mucosal \u03b3\u03b4 T cell receptor V region repertoire in patients with IgA nephropathy. Kidney Int. 52, 1047\u20131053 (1997).","journal-title":"Kidney Int."},{"key":"BFnrneph2015208_CR44","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/0090-1229(83)90130-7","volume":"26","author":"NG Westberg","year":"1983","unstructured":"Westberg, N. G., Baklien, K., Schmekel, B., Gillberg, R. & Brandtzaeg, P. Quantitation of immunoglobulin-producing cells in small intestinal mucosa of patients with IgA nephropathy. Clin. Immunol. Immunopathol. 26, 442\u2013445 (1983).","journal-title":"Clin. Immunol. Immunopathol."},{"key":"BFnrneph2015208_CR45","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1440-1797.1997.tb00188.x","volume":"3","author":"SN Emancipator","year":"1997","unstructured":"Emancipator, S. N., Chintalacharuvu, S. R. & Bagheri, N. Animal models of IgA nephropathy: formulating therapeutic strategies. Nephrol. (Carlton) 3, 45\u201350 (1997).","journal-title":"Nephrol. (Carlton)"},{"key":"BFnrneph2015208_CR46","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1172\/JCI20096","volume":"113","author":"J Wang","year":"2004","unstructured":"Wang, J. et al. Dysregulated LIGHT expression on T cells mediates intestinal inflammation and contributes to IgA nephropathy. J. Clin. Invest. 113, 826\u2013835 (2004).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph2015208_CR47","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1159\/000169050","volume":"16","author":"T Kovacs","year":"1996","unstructured":"Kovacs, T. et al. Do intestinal hyperpermeability and the related food antigens play a role in the progression of IgA nephropathy? I. Study of intestinal permeability. Am. J. Nephrol. 16, 500\u2013505 (1996).","journal-title":"Am. J. Nephrol."},{"key":"BFnrneph2015208_CR48","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1159\/000187211","volume":"63","author":"G Rostoker","year":"1993","unstructured":"Rostoker, G. et al. Mucosal immunity in primary glomerulonephritis. III. Study of intestinal permeability. Nephron 63, 286\u2013290 (1993).","journal-title":"Nephron"},{"key":"BFnrneph2015208_CR49","first-page":"65","volume":"137","author":"T Kovacs","year":"1996","unstructured":"Kovacs, T. et al. Relationship between intestinal permeability and antibodies against food antigens in IgA nephropathy. Orv. Hetil. 137, 65\u201369 (in Hungarian) (1996).","journal-title":"Orv. Hetil."},{"key":"BFnrneph2015208_CR50","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/j.1651-2227.1988.tb10609.x","volume":"77","author":"JC Davin","year":"1988","unstructured":"Davin, J. C., Forget, P. & Mahieu, P. R. Increased intestinal permeability to (51 Cr) EDTA is correlated with IgA immune complex-plasma levels in children with IgA-associated nephropathies. Acta Paediatr. Scand. 77, 118\u2013124 (1988).","journal-title":"Acta Paediatr. Scand."},{"key":"BFnrneph2015208_CR51","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1159\/000186821","volume":"60","author":"JC Davin","year":"1992","unstructured":"Davin, J. C. & Mahieu, P. R. Sequential measurements of intestinal permeability to [51Cr]EDTA in children with Henoch\u2013Sch\u00f6nlein purpura nephritis. Nephron 60, 498\u2013499 (1992).","journal-title":"Nephron"},{"key":"BFnrneph2015208_CR52","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1093\/ndt\/5.8.569","volume":"5","author":"L Layward","year":"1990","unstructured":"Layward, L., Hattersley, J. M., Patel, H. R., Tanner, M. S. & Feehally, J. Gut permeability in IgA nephropathy. Nephrol. Dial. Transplant. 5, 569\u2013571 (1990).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph2015208_CR53","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1159\/000185212","volume":"50","author":"DA Jenkins","year":"1988","unstructured":"Jenkins, D. A., Bell, G. M., Ferguson, A. & Lambie, A. T. Intestinal permeability in IgA nephropathy. Nephron 50, 390 (1988).","journal-title":"Nephron"},{"key":"BFnrneph2015208_CR54","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1136\/adc.64.6.853","volume":"64","author":"S Hodges","year":"1989","unstructured":"Hodges, S., Ashmore, S. P., Patel, H. R. & Tanner, M. S. Cellobiose: mannitol differential permeability in small bowel disease. Arch. Dis. Child. 64, 853\u2013855 (1989).","journal-title":"Arch. Dis. Child."},{"key":"BFnrneph2015208_CR55","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1159\/000186870","volume":"61","author":"C Bazzi","year":"1992","unstructured":"Bazzi, C. et al. Low doses of drugs able to alter intestinal mucosal permeability to food antigens (5-aminosalicylic acid and sodium cromoglycate) do not reduce proteinuria in patients with IgA nephropathy: a preliminary noncontrolled trial. Nephron 61, 192\u2013195 (1992).","journal-title":"Nephron"},{"key":"BFnrneph2015208_CR56","first-page":"141","volume":"27","author":"M Sato","year":"1987","unstructured":"Sato, M., Nakajima, Y. & Koshikawa, S. Effect of sodium cromoglycate on an experimental model of IgA nephropathy. Clin. Nephrol. 27, 141\u2013146 (1987).","journal-title":"Clin. Nephrol."},{"key":"BFnrneph2015208_CR57","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3349\/ymj.1990.31.1.33","volume":"31","author":"SY Jin","year":"1990","unstructured":"Jin, S. Y. & Choi, I. J. The effect of sodium cromoglycate on the induction of experimental IgA nephropathy. Yonsei Med. J. 31, 33\u201348 (1990).","journal-title":"Yonsei Med. J."},{"key":"BFnrneph2015208_CR58","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0272-6386(12)80511-7","volume":"15","author":"M Sato","year":"1990","unstructured":"Sato, M., Takayama, K., Kojima, H. & Koshikawa, S. Sodium cromoglycate therapy in IgA nephropathy: a preliminary short-term trial. Am. J. Kidney Dis. 15, 141\u2013146 (1990).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph2015208_CR59","doi-asserted-by":"publisher","first-page":"3237","DOI":"10.1093\/ndt\/gfr052","volume":"26","author":"HK Smerud","year":"2011","unstructured":"Smerud, H. K. et al. New treatment for IgA nephropathy: enteric budesonide targeted to the ileocecal region ameliorates proteinuria. Nephrol. Dial. Transplant. 26, 3237\u20133242 (2011).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph2015208_CR60","unstructured":"US National Library of Science. ClinicalTrials.gov [online] , (2015)."},{"key":"BFnrneph2015208_CR61","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.semnephrol.2007.10.004","volume":"28","author":"S Pouria","year":"2008","unstructured":"Pouria, S. & Barratt, J. Secondary IgA nephropathy. Semin. Nephrol. 28, 27\u201337 (2008).","journal-title":"Semin. Nephrol."},{"key":"BFnrneph2015208_CR62","first-page":"324","volume":"107","author":"H Helin","year":"1983","unstructured":"Helin, H., Mustonen, J., Reunala, T. & Pasternack, A. IgA nephropathy associated with celiac disease and dermatitis herpetiformis. Arch. Pathol. Lab. Med. 107, 324\u2013327 (1983).","journal-title":"Arch. Pathol. Lab. Med."},{"key":"BFnrneph2015208_CR63","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1681\/ASN.2005070714","volume":"17","author":"RD Pawar","year":"2006","unstructured":"Pawar, R. D. et al. Toll-like receptor-7 modulates immune complex glomerulonephritis. J. Am. Soc. Nephrol. 17, 141\u2013149 (2006).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2015208_CR64","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/j.1365-2249.2009.04045.x","volume":"159","author":"R Coppo","year":"2010","unstructured":"Coppo, R. et al. Toll-like receptor 4 expression is increased in circulating mononuclear cells of patients with immunoglobulin A nephropathy. Clin. Exp. Immunol. 159, 73\u201381 (2010).","journal-title":"Clin. Exp. Immunol."},{"key":"BFnrneph2015208_CR65","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1681\/ASN.2007121311","volume":"19","author":"H Suzuki","year":"2008","unstructured":"Suzuki, H. et al. Toll-like receptor 9 affects severity of IgA nephropathy. J. Am. Soc. Nephrol. 19, 2384\u20132395 (2008).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2015208_CR66","first-page":"56","volume":"34","author":"A Pasternack","year":"1990","unstructured":"Pasternack, A. et al. Glomerular IgA deposits in patients with celiac disease. Clin. Nephrol. 34, 56\u201360 (1990).","journal-title":"Clin. Nephrol."},{"key":"BFnrneph2015208_CR67","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1093\/ndt\/gfu343","volume":"30","author":"R Coppo","year":"2015","unstructured":"Coppo, R. The intestine-renal connection in IgA nephropathy. Nephrol. Dial. Transplant. 30, 360\u2013366 (2015).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph2015208_CR68","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/ki.2015.94","volume":"88","author":"C Papista","year":"2015","unstructured":"Papista, C. et al. Gluten exacerbates IgA nephropathy in humanized mice through gliadin\u2013CD89 interaction. Kidney Int. 88, 276\u2013285 (2015).","journal-title":"Kidney Int."},{"key":"BFnrneph2015208_CR69","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1084\/jem.20071204","volume":"205","author":"T Matysiak-Budnik","year":"2008","unstructured":"Matysiak-Budnik, T. et al. Secretory IgA mediates retrotranscytosis of intact gliadin peptides via the transferrin receptor in celiac disease. J. Exp. Med. 205, 143\u2013154 (2008).","journal-title":"J. Exp. Med."},{"key":"BFnrneph2015208_CR70","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1097\/01.ASN.0000046961.04917.83","volume":"14","author":"E Haddad","year":"2003","unstructured":"Haddad, E. et al. Enhanced expression of the CD71 mesangial IgA1 receptor in Berger disease and Henoch\u2013Sch\u00f6nlein nephritis: association between CD71 expression and IgA deposits. J. Am. Soc. Nephrol. 14, 327\u2013337 (2003).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2015208_CR71","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1053\/j.gastro.2012.05.051","volume":"143","author":"C Lebreton","year":"2012","unstructured":"Lebreton, C. et al. Interactions among secretory immunoglobulin A, CD71, and transglutaminase-2 affect permeability of intestinal epithelial cells to gliadin peptides. Gastroenterology 143, 698\u2013707.e4 (2012).","journal-title":"Gastroenterology"},{"key":"BFnrneph2015208_CR72","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1084\/jem.20112005","volume":"209","author":"L Berthelot","year":"2012","unstructured":"Berthelot, L. et al. Transglutaminase is essential for IgA nephropathy development acting through IgA receptors. J. Exp. Med. 209, 793\u2013806 (2012).","journal-title":"J. Exp. Med."},{"key":"BFnrneph2015208_CR73","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1097\/MCG.0b013e318284792e","volume":"47","author":"A Welander","year":"2013","unstructured":"Welander, A., Sundelin, B., Fored, M. & Ludvigsson, J. F. Increased risk of IgA nephropathy among individuals with celiac disease. J. Clin. Gastroenterol. 47, 678\u2013683 (2013).","journal-title":"J. Clin. Gastroenterol."},{"key":"BFnrneph2015208_CR74","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.1111\/j.1572-0241.2002.06025.x","volume":"97","author":"P Collin","year":"2002","unstructured":"Collin, P. et al. Celiac disease and HLA DQ in patients with IgA nephropathy. Am. J. Gastroenterol. 97, 2572\u20132576 (2002).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrneph2015208_CR75","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/S0272-6386(12)80644-5","volume":"17","author":"R Coppo","year":"1991","unstructured":"Coppo, R. et al. IgA antibodies to dietary antigens and lectin-binding IgA in sera from Italian, Australian, and Japanese IgA nephropathy patients. Am. J. Kidney Dis. 17, 480\u2013487 (1991).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph2015208_CR76","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1159\/000013497","volume":"19","author":"M Ots","year":"1999","unstructured":"Ots, M., Uibo, O., Metskula, K., Uibo, R. & Salupere, V. IgA-antigliadin antibodies in patients with IgA nephropathy: the secondary phenomenon? Am. J. Nephrol. 19, 453\u2013458 (1999).","journal-title":"Am. J. Nephrol."},{"key":"BFnrneph2015208_CR77","doi-asserted-by":"publisher","first-page":"339","DOI":"10.3109\/2000-1967-060","volume":"111","author":"G Almroth","year":"2006","unstructured":"Almroth, G. et al. Increased prevalence of anti-gliadin IgA-antibodies with aberrant duodenal histopathological findings in patients with IgA-nephropathy and related disorders. Ups. J. Med. Sci. 111, 339\u2013352 (2006).","journal-title":"Ups. J. Med. Sci."},{"key":"BFnrneph2015208_CR78","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1159\/000184877","volume":"48","author":"G Rostoker","year":"1988","unstructured":"Rostoker, G. et al. Lack of antireticulin and IgA antiendomysium antibodies in sera of patients with primary IgA nephropathy associated with circulating IgA antibodies to gliadin. Nephron 48, 81 (1988).","journal-title":"Nephron"},{"key":"BFnrneph2015208_CR79","doi-asserted-by":"crossref","first-page":"S173","DOI":"10.1681\/ASN.V210s173","volume":"2","author":"R Coppo","year":"1992","unstructured":"Coppo, R., Amore, A. & Roccatello, D. Dietary antigens and primary immunoglobulin A nephropathy. J. Am. Soc. Nephrol. 2, S173\u2013S180 (1992).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2015208_CR80","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1053\/ajkd.2002.33387","volume":"39","author":"A Pierucci","year":"2002","unstructured":"Pierucci, A. et al. Antiendomysial antibodies in Berger's disease. Am. J. Kidney Dis. 39, 1176\u20131182 (2002).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph2015208_CR81","doi-asserted-by":"publisher","first-page":"265","DOI":"10.2215\/CJN.04660513","volume":"9","author":"JM Ambruzs","year":"2014","unstructured":"Ambruzs, J. M., Walker, P. D. & Larsen, C. P. The histopathologic spectrum of kidney biopsies in patients with inflammatory bowel disease. Clin. J. Am. Soc. Nephrol. 9, 265\u2013270 (2014).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph2015208_CR82","first-page":"1083","volume":"13","author":"D Hubert","year":"1984","unstructured":"Hubert, D., Beaufils, M. & Meyrier, A. Immunoglobulin A glomerular nephropathy associated with inflammatory colitis. Apropos of 2 cases. Presse Med. 13, 1083\u20131085 (in French) (1984).","journal-title":"Presse Med."},{"key":"BFnrneph2015208_CR83","first-page":"30","volume":"12","author":"G Stirati","year":"1999","unstructured":"Stirati, G., Antonelli, M., Fofi, C., Fierimonte, S. & Pecci, G. IgA nephropathy in cystic fibrosis. J. Nephrol. 12, 30\u201331 (1999).","journal-title":"J. Nephrol."},{"key":"BFnrneph2015208_CR84","doi-asserted-by":"publisher","first-page":"921","DOI":"10.2215\/CJN.00750209","volume":"4","author":"Y Yahiaoui","year":"2009","unstructured":"Yahiaoui, Y. et al. Renal involvement in cystic fibrosis: diseases spectrum and clinical relevance. Clin. J. Am. Soc. Nephrol. 4, 921\u2013928 (2009).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph2015208_CR85","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1093\/ndt\/gfr403","volume":"27","author":"D Sato","year":"2012","unstructured":"Sato, D. et al. Tonsillar TLR9 expression and efficacy of tonsillectomy with steroid pulse therapy in IgA nephropathy patients. Nephrol. Dial. Transplant. 27, 1090\u20131097 (2012).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph2015208_CR86","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1093\/ndt\/gfu020","volume":"29","author":"T Kawamura","year":"2014","unstructured":"Kawamura, T. et al. A multicenter randomized controlled trial of tonsillectomy combined with steroid pulse therapy in patients with immunoglobulin A nephropathy. Nephrol. Dial. Transplant. 29, 1546\u20131553 (2014).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph2015208_CR87","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s40620-014-0086-8","volume":"28","author":"L Vergano","year":"2015","unstructured":"Vergano, L. et al. Can tonsillectomy modify the innate and adaptive immunity pathways involved in IgA nephropathy? J. Nephrol. 28, 51\u201358 (2015).","journal-title":"J. Nephrol."},{"key":"BFnrneph2015208_CR88","doi-asserted-by":"publisher","unstructured":"Feehally, J. et al. Tonsillectomy in a European cohort of 1147 patients with IgA nephropathy. Nephron Clin. Pract. http:\/\/dx.doi.org\/10.1159\/000441852 (2015).","DOI":"10.1159\/000441852"}],"container-title":["Nature Reviews Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2015.208.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2015.208","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2015.208.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T09:39:47Z","timestamp":1692178787000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrneph.2015.208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,30]]},"references-count":88,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["BFnrneph2015208"],"URL":"https:\/\/doi.org\/10.1038\/nrneph.2015.208","relation":{},"ISSN":["1759-5061","1759-507X"],"issn-type":[{"value":"1759-5061","type":"print"},{"value":"1759-507X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,30]]},"assertion":[{"value":"30 December 2015","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J. Floege has received honoraria from Pharmalink, Sweden. J. Feehally declares no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}